Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 32, Issue 8, 2008, Pages 653-658

  Coulter, Cynthia ^a   Miller, Elizabeth ^a   Crompton, Katherine ^a   Moore, Christine ^a  

^a Immunalysis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYDRONABINOL; CANNABINOID DERIVATIVE; DRONABINOL; TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; ELECTROSPRAY; HUMAN; LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 56449127783     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.8.653     Document Type: Article

References (10)

1. L.J. Farrell, S. Kerrigan, and B.K. Logan. Recommendations for toxicological investigation of drug impaired driving. J. Forensic Sci. 52(5): 1214-1218 (2007).
2. 9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry. J. Anal. Toxicol. 30(4): 262-266 (2006).
3. 9-THC in whole blood using gas chromatography-mass spectrometry. J. Anal. Toxicol. 26(8): 575-581 (2002).
4. A. Thomas, C. Widmer, G. Hopfgartner, and C. Staub. Fast gas chromatography and negative ion chemical ionization tandem mass spectrometry for forensic analysis of cannabinoids in whole blood. J. Pharm. Biomed. Anal. 45(3): 495-503 (2007).
5. B. Maralikova and W. Weinmann. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J. Chromatogr. B 811(1): 21-30 (2004).
6. B. Maralikova and W. Weinmann. Simultaneous determination of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetra hydrocannabinol and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 39: 526-531 (2004).
7. E. Chambers, D.M. Wagrowski-Diehl, Z. Lu, and J.R. Mazzeo. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 852: 22-34 (2007).
8. H.Z. Khiabani, J.G. Bramness, A. Bjorneboe, and J. Morland. Relationship between THC concentration in blood and impairment in apprehended drivers. Traffic Inj. Prev. 7(2): 111-116 (2006).
9. A. Menetry, M. Augsburger, B. Favrat, M.A. Pin, L.E. Rothuizen, M. Appenzeller, T. Buclin, P. Mangin, and C. Giroud. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Δ9-THC. J. Anal. Toxicol. 29(5): 327-338 (2005).
10. J.R. Johnson, T.A. Jennison, M.A. Peat, and R.L. Foltz. Stability of delta-9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in blood and plasma. J. Anal. Toxicol. 8(5): 202-204 (1984).